Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines

被引：52
|
作者：
Gawad, Nagwa M. Abdel [1 ]
Amin, Noha H. [2 ]
Elsaadi, Mohammed T. [2 ]
Mohamed, Fatma M. M. [2 ]
Angeli, Andrea [3 ]
De Luca, Viviana [4 ]
Capasso, Clemente [4 ]
Supuran, Claudiu T. [3 ]
机构：
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11562, Egypt
[2] Beni Suef Univ, Dept Med Chem, Fac Pharm, Bani Suwayf 62514, Egypt
[3] Univ Florence, Dipartimento Neurofarba, Sez Sci Farmaceut & Nutraceut, Via U Schiff 6, I-50019 Florence, Italy
[4] CNR, Ist Biosci & Biorisorse, Via Pietro Castellino 81, I-80125 Naples, Italy
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2016年 / 24卷 / 13期
关键词：
Carbonic anhydrase; Inhibitor; Sulfonamide; Antitumor; Cytotoxic agent; RAY CRYSTAL-STRUCTURE; HUMAN ISOFORM-II; ISOZYME-II; SELECTIVE INHIBITORS; THERAPEUTIC APPLICATIONS; SULFONAMIDE DERIVATIVES; XII INHIBITORS; BINDING; ANTICANCER; HYPOXIA;
D O I：
10.1016/j.bmc.2016.05.016
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A series of 4-(thiazol-2-ylamino)-benzenesulfonamides was synthesized and screened for their carbonic anhydrase (CA, EC 4.2.1.1) inhibitory and cytotoxic activity on human breast cancer cell line MCF-7. Human (h) CA isoforms I, II and IX were included in the study. The new sulfonamides showed excellent inhibition of all three isoforms, with K(I)s in the range of 0.84-702 nM against hCA I, of 0.41-288 nM against hCA II and of 5.6-29.2 against the tumor-associated hCA IX, a validated anti-tumor target, with a sulfonamide (SLC-0111) in Phase I clinical trials for the treatment of hypoxic, metastatic solid tumors overexpressing CA IX. The new compounds showed micromolar inhibition of growth efficacy against breast cancer MCF-7 cell lines. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3043 / 3051
页数：9
相关论文
共 50 条
  • [31] Synthesis of Novel 4-(1H-benzimidazol-2-yl)benzene-1,3-diols and their Cytotoxic Activity against Human Cancer Cell Lines
    Karpinska, Monika M.
    Matysiak, Joanna
    Niewiadomy, Andrzej
    ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (10) : 1639 - 1647
  • [32] New compounds based on a benzimidazole nucleus: synthesis, characterization and cytotoxic activity against breast and colon cancer cell lines
    Akkoc, Senem
    Kayser, Veysel
    Ilhan, Ilhan Ozer
    Hibbs, David E.
    Gok, Yetkin
    Williams, Peter A.
    Hawkins, Bryson
    Lai, Felcia
    JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2017, 839 : 98 - 107
  • [33] Synthesis of novel 4-(1H-benzimidazol-2-yl)benzene-1,3-diols and their cytotoxic activity against human cancer cell lines
    Monika M. Karpińka
    Joanna Matysiak
    Andrzej Niewiadomy
    Archives of Pharmacal Research, 2011, 34 : 1639 - 1647
  • [34] Synthesis of 17β-estradiol-platinum(II) hybrid molecules showing cytotoxic activity on breast cancer cell lines
    Provencher-Mandeville, Josee
    Descoteaux, Caroline
    Mandal, Sanat K.
    Leblanc, Valerie
    Asselin, Eric
    Berube, Gervais
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (07) : 2282 - 2287
  • [35] Synthesis of C4-fluorinated solamins and their growth inhibitory activity against human cancer cell lines
    Kojima, Naoto
    Hayashi, Hiromi
    Suzuki, Satoshi
    Tominaga, Hiroaki
    Maezaki, Naoyoshi
    Tanaka, Tetsuaki
    Yamori, Takao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (24) : 6451 - 6453
  • [36] Novel Re(I) tricarbonyl coordination compounds based on 2-pyridyl-1,2,3-triazole derivatives bearing a 4-amino-substituted benzenesulfonamide arm: synthesis, crystal structure, computational studies and inhibitory activity against carbonic anhydrase I, II, and IX isoforms†
    Aimene, Yassine
    Eychenne, Romain
    Mallet-Ladeira, Sonia
    Saffon, Nathalie
    Winum, Jean-Yves
    Nocentini, Alessio
    Supuran, Claudiu T.
    Benoist, Eric
    Seridi, Achour
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 773 - 782
  • [37] Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene) amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies
    Eldehna, Wagdy M.
    Abo-Ashour, Mahmoud F.
    Nocentini, Alessio
    Gratteri, Paola
    Eissa, Ibrahim H.
    Fares, Mohamed
    Ismael, Omnia E.
    Ghabbour, Hazem A.
    Elaasser, Mahmoud M.
    Abdel-Aziz, Hatem A.
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 139 : 250 - 262
  • [38] Carbonic anhydrase inhibitors: Inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides
    Saczewski, Franciszek
    Innocenti, Alessio
    Slawinski, Jaroslaw
    Kornicka, Anita
    Brzozowski, Zdzislaw
    Pomarnacka, Elzbieta
    Scozzafava, Andrea
    Temperini, Claudia
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (07) : 3933 - 3940
  • [39] Synthesis, biological evaluation and in silico studies with 4-benzylidene-2phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity
    Eldehna, Wagdy M.
    Abdelrahman, Mohamed A.
    Nocentini, Alessio
    Bua, Silvia
    Al-Rashood, Sara T.
    Hassan, Ghada S.
    Bonardi, Alessandro
    Almehizia, Abdulrahman A.
    Alkahtani, Hamad M.
    Alharbi, Amal
    Gratteri, Paola
    Supuran, Claudiu T.
    BIOORGANIC CHEMISTRY, 2019, 90
  • [40] A COMBINATION OF 2 IMMUNOTOXINS EXERTS SYNERGISTIC CYTOTOXIC ACTIVITY AGAINST HUMAN BREAST-CANCER CELL-LINES
    CREWS, JR
    MAIER, LA
    YIN, HY
    HESTER, S
    OBRIANT, K
    LESLIE, DS
    DESOMBRE, K
    GEORGE, SL
    BOYER, CM
    ARGON, Y
    BAST, RC
    INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (05) : 772 - 779
12345